Dupilumab as a novel therapy for epidermolysis bullosa pruriginosa.

Shao, Lei; Zhong, Dao-Qing; Liu, Yu-Mei; Wang, Jian-Qin

Shao, Lei; Zhong, Dao-Qing; Liu, Yu-Mei; Wang, Jian-Qin.

Affiliation

Shao L; Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, China.
Zhong DQ; Institute of Dermatology, Guangzhou Medical University, Guangzhou, China.
Liu YM; Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, China.
Wang JQ; Institute of Dermatology, Guangzhou Medical University, Guangzhou, China.

Int J Dermatol ; 62(10): e542-e545, 2023 10.

Article in En | MEDLINE | ID: mdl-37326291

Subject(s)

Epidermolysis Bullosa Dystrophica; Epidermolysis Bullosa; Humans; Epidermolysis Bullosa Dystrophica/drug therapy; Antibodies, Monoclonal, Humanized/therapeutic use; Collagen Type VII

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epidermolysis Bullosa Dystrophica / Epidermolysis Bullosa Limits: Humans Language: En Journal: Int J Dermatol Year: 2023 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google